Scientific Online Resource System

International Bulletin of Otorhinolaryngology

Mastoid cavity obliteration in treatment of middle ear cholesteatoma

P. Rouev

Abstract

Objective: The primary goal in the surgical management of chronic otitis media with cholesteatoma is the creation of a dry and safe ear. The method of choice for management of cholesteatoma is the inside out or reverse mastoidectomy. If external auditory canal reconstruction after complete cholesteatoma removal is not possible, mastoid cavity obliteration techniques are recommended to reduce the size of the open mastoid cavity. The goal of our study is to evaluate the frequency of postoperative ear secretion and hearing situation in patients with mastoid cavity obliteration in treatment of middle ear cholesteatoma.
Methods: Retrospective study of 155 patients with middle ear cholesteatoma were surgically treatment during 52 months from 01.06.2014 to 30.09.2018 in Hospital Trakia Park, Stara Zagora (Bulgaria) with canal wall reconstruction or mastoid cavity obliteration with cartilage, bone paté or bone replacement alloplastic materials.
Results: After complete cholesteatoma removal we perform ear canal reconstruction in 51.61% of cases (80; n=155), and in others 41.94% of cases (65; n=155) we perform mastoid cavity obliteration. In our patient group we perform type I tympanoplasty in 36.77% (57; n=155), type III tympanoplasty in 46.45% (72; n=155), Secondlook operations in 14% (21, n = 155) and only in 5 cases we left the operating cavity open (3.23%; n=155). After mean follow-up period from 11.34 months (1÷48 months; SD 13.10 months) our frequency of postoperative ear secretion is 6.45% (10; n=155) and our cholesteatoma residual rate is 9.03% (14; n=155).
Conclusion: Mastoid cavity obliteration procedures can prevent the development of postoperative retraction pockets by isolation the tympanic cavity from the attic and mastoid. This is a safe and effective technique for rehabilitation of mastoid cavities. Hearing results of this technique is variable according to the involvement of the middle ear ossicles, but with the possibility of fitting a hearing aids or middle ear implants.

Keywords

Middle ear cholesteatoma, Mastoid cavity obliteration, Inside out mastoidectomy, Residual cholesteatoma

Full Text


References

Jahnke K, Khatib M, Rau U (1985) Langzeitergebnisse nach Cholesteatomchirurgie. Lar Rhinol Otol 64: 238–242.

Trinidade A, Skingsley A, Yung MW (2015) Mastoid obliteration surgery for cholesteatoma in 183 adult ears – a 5-year prospective cohort study: Our Experience. Clinical Otolaryngology 40: 715–736.

Plester D, Hildmann H, Steinbach E. (1989) Atlas der Ohrchirurgie. Stuttgart: Kohlhammer p.84.

Mosher HP. (1911) A method filling the excavated mastoid with a flap from the back of the auricle. Laryngoscope 21: 1158–1163.

Mehrin S, Sumit K G,Sunil N D. (2018) The Forgotten Rambo Flap for Mastoid Cavity Obliteration. Glob J Oto 17(4): 61–63.

Palva T. (1963) Surgery of chronic ear without cavity. Archives of Otolaryngology 570–580.

Sarin J, Grenman R, Aitasalo K, Pulkkinen J. (2012) Bioactive Glass S53P4 in Mastoid Obliteration Surgery for Chronic Otitis Media and Cerebrospinal Fluid Leakage. Annals of Otology, Rhinology & Laryngology 121: 563–569.

Hildmann H, Sudhoff H, Jahnke K. (2004) Principles of an Individualized Approach to Cholesteatoma Surgery, Middle Ear Surgery. [In: Current Topics in Otolaryngology – Head and Neck Surgery: Middle Ear Surgery – Recent Advances and Future Directions, K. Jahke (Ed.)], Georg Thieme Verlag pp. 73–93.

Hildmann H. (1986) Mastoidhoehle und Gehoergangseingangsplastik. Laryngol-Rhinol-Otol 65: 684–687.

Jussi Sarin, Reidar Grénman, Kalle Aitasalo, Jaakko Pulkkinen. (2012) Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage. Ann Otol Rhinol Laryngol 121(9): 563–9.

Stoor Patricia et al. (2001) Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media. Annals of Otology, Rhinology & Laryngolog 119(6): 377–382.

Blayney AW, Erre J-P, Dhem A, Cazals Y. (1989) Experimental Mastoid Obliteration with Hydroxyapatite Tricalcium Phosphate (Zimmer/Xomed) and Fibrin Glue (Immuno-Austria). Proceedings of the First International Conference on Interfaces in Medicine and Mechanics pp. 204–214.

Jang CH, Choi CH, Cho YB. (2016) Effect of BMP2-Platelet-rich Plasma-Biphasic Calcium Phosphate Scaffold on Accelerated Osteogenesis in Mastoid Obliteration. In Vivo 30(6): 835–839.

Mirko Tos. (1997) Manual of Middle Ear Surgery, Vol. 2: Mastoid Surgery and Reconstructive Procedures pp. 310–314.

Paparella et al. (1991) Otolayngology Volume II: Otology and Neuro-Otology, Third Edition pp. 1432–5.

Matthew Yung, Tetsuya Tono, Ewa Olszewska, Yutaka Yamamoto, Holger Sudhoff, Masafumi Sakagami, Jef Mulder, Hiromi Kojima, Armağan İncesulu, Franco Trabalzini, Nuri Özgirgin. (2017) EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma. J Int Adv Otol 13(1): 1–8.

Peter MM, Li C, Eleni Linos, Richard K. Gurgel, Nancy J. Fischbein, Nikolas H. Blevins. (2013) Evaluating the utility of non–echo–planar diffusion–weighted imaging in the preoperative evaluation of cholesteatoma: A meta–analysis. Laryngoscope 123(5): 1247–50.

Pai, Irumee; Crossley, Eleanor; Lancer, Hannah; Dudau, Cristina; Connor, Stephen. (2019) Growth and Late Detection of Post-Operative Cholesteatoma on Long Term Follow-Up With Diffusion Weighted Magnetic Resonance Imaging (DWI MRI). Otol Neurotol 40(5): 638–644.

Lingam R, Singh A. (2015) Detecting postoperative cholesteatoma with diffusion weighted magnetic resonance imaging. ENT & Audiology News 23(2): 56–57.

Kartush JM. (1994) Ossicular chain reconstruction. Capitulum to malleus. Otolaryngol Clin North Am 27: 689–715.

Csakanyi Zsuzsanna, Katona Gabor, Konya Denes, Mohos Ferenc, Sziklai Istvan. (2014) Middle Ear Gas Pressure Regulation: The Relevance of Mastoid Obliteration. Otol Neurotol 35(6): 944–953.

James L. Sheehy, Derald E. Brackmann, Malcolm D. Graham. (1977) Cholesteatoma Surgery: Residual and Recurrent Disease: A Review Of 1,024 Cases. Annals of Otology, Rhinology & Laryngology 86(4): 451–462.

Tarabichi M. (1997) Endoscopic management of acquired cholesteatoma. Am J Otol. 18(5): 544–9.

James L. Sheehy, Derald E. Brackmann, Malcolm D. Graham. Cholesteatoma Surgery: Residual and Recurrent Disease: A Review Of 1,024 Cases, Annals of Otology, Rhinology & Laryngology 86(4): 451–462.

Roberson Joseph B Jr, Mason Theodore P, Stidham Katrina R. (2003) Mastoid Obliteration: Autogenous Cranial Bone Paté Reconstruction. Otology & Neurotology 24(2): 132–140.

Yung M, Jacobsen NL, Vowler SL. (2007) A 5-year observational study of the outcome in pediatric cholesteatoma surgery. Otol Neurotol 28: 1038–40.

Martin Bremke, Karl-Bernd Hüttenbrink, Dirk Beutner. (2011) The sandwich cartilage shoe technique for ossicular reconstruction in a case of an unsecure stapes footplate. The Laryngoscope 121(9): 1950–1952.

Linder Thomas, Shankar Shah, Aline Silveira Martha, Christof Roosli, Susan D. (2018) Emmett. Introducing the ‘‘CHOLE’’ Classification and Its Comparison to the EAONO/JOS Consensus Classification for Cholesteatoma Staging. Otology & Neurotology 40: 63–72.




DOI: http://dx.doi.org/10.14748/orl.v16i4.7737

Refbacks

Font Size


|